Healthcare

InStride Health, a Specialty Provider of Pediatric Anxiety/OCD Outpatient Treatment, Expands Access for Youth in Virginia

RICHMOND, VA / ACCESSWIRE / August 27, 2024 / InStride Health, an outpatient provider of specialty pediatric anxiety and OCD…

4 months ago

InStride Health, a Specialty Pediatric Anxiety/OCD Outpatient Treatment Provider, Expands Access for Youth in Ohio

CLEVELAND, OH / ACCESSWIRE / August 27, 2024 / InStride Health, an outpatient provider of specialty pediatric anxiety and OCD…

4 months ago

CervoMed to Participate in Upcoming Investor Conferences

BOSTON, Aug. 27, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for…

4 months ago

Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters

The Congresswoman representing Georgia’s 7th district in the U.S. House of Representatives toured Femasys’ facilities to gain a better understanding…

4 months ago

Korro to Participate in Upcoming September Investor and Scientific Conferences

CAMBRIDGE, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing…

4 months ago

Spectral AI Completes Burn Center Enrollment for U.S. Burn Pivotal Study

Milestone Achievement Advances Commercialization Timeline for DeepView™ System for Burn IndicationDALLAS, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc.…

4 months ago

Rezolute to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease…

4 months ago

Therma Bright Major Milestone: Portfolio Company Inretio’s Preva(R) Device Achieves 3rd Human Trial Success

Game-Changing Innovation Poised to Transform Stroke and Blood Clot TreatmentTherma Bright's Strategic Investment Helps Medical Device Company Demonstrate Efficacy and…

4 months ago

myTomorrows and Pancreatic Cancer Europe Partner to Support Pancreatic Cancer Patients in Accessing Clinical Trials

Partnership with the European patient advocacy group furthers myTomorrows' mission to expand access to all possible treatment options for patients…

4 months ago

LIAN Group Expands Healthcare Platform with Strategic Acquisition of Scientis, #1 Dermatologist-Recommended Solution for Hyperpigmentation

GENEVA, Aug. 27, 2024 /PRNewswire/ -- As part of their Healthcare investment platform, LIAN Group, an innovative investor and operator…

4 months ago